Net Income (Loss) Attributable to Parent in USD of MANGOCEUTICALS, INC. from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
MANGOCEUTICALS, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2022 to Q3 2025.
  • MANGOCEUTICALS, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$7.62M, a 281% decline year-over-year.
  • MANGOCEUTICALS, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$19.8M, a 113% decline year-over-year.
  • MANGOCEUTICALS, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$8.71M, a 5.5% increase from 2023.
  • MANGOCEUTICALS, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.21M, a 361% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

MANGOCEUTICALS, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$19.8M -$7.62M -$5.62M -281% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$14.2M -$5.42M -$3.02M -127% 01 Apr 2025 30 Jun 2025 10-Q/A 14 Nov 2025
Q1 2025 -$11.2M -$4.84M -$2.47M -104% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$8.71M -$1.95M +$620K +24.1% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$9.33M -$2M -$200K -11.1% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$9.13M -$2.39M -$107K -4.68% 01 Apr 2024 30 Jun 2024 10-Q/A 14 Nov 2025
Q1 2024 -$9.02M -$2.37M +$193K +7.55% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$9.21M -$2.57M -$1.89M -281% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$7.32M -$1.8M -$805K -80.9% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$6.51M -$2.28M -$1.97M -636% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$4.54M -$2.56M -$2.54M -12966% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$2M -$673K 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 -$995K 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 -$310K 01 Apr 2022 30 Jun 2022 10-Q 27 Oct 2023
Q1 2022 -$19.6K 01 Jan 2022 31 Mar 2022 10-Q 27 Oct 2023

MANGOCEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$8.71M +$506K +5.5% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$9.21M -$7.21M -361% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$2M 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.